跳至主要内容
临床试验/EUCTR2016-003544-37-GB
EUCTR2016-003544-37-GB进行中(未招募)1 期

Perineural Local Anaesthetic Catheter aftEr Major lowEr limb amputatioN Trial (PLACEMENT) - PLACEMENT

Aneurin Bevan University Health Board0 个研究点目标入组 50 人开始时间: 2017年4月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The following patients are suitable for inclusion into the study:
  • patients aged 18 years or older
  • undergoing elective or emergency major lower limb amputations (BKA, or AKA) for complications of PVD
  • able to assess pain using a VRS
  • those with a life expectancy of greater than two weeks
  • (for women of childbearing potential) willing to undergo a pregnancy test before the trial and agree to either use a highly effective method of contraception or abstain from sexual intercourse until at least seven days after their amputation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • The following patients are not suitable for inclusion into the study:
  • patients undergoing digital, metatarsal, tarsal amputation, disarticulation of the hip or hindquarter amputation
  • patients undergoing simultaneous bilateral amputations
  • patients undergoing through knee amputation (TKA)
  • patients who are unable to provide consent due to incapacity (as defined by Mental Capacity Act 2005)
  • vulnerable or protected adults
  • patients with an allergy or intolerance to any of the substances in the PNC, or local anaesthetic agents, or chronically taking class IB anti-arrhythmic agents or local anaesthetic agents, for example in the form of transdermal patches.
  • pregnant females
  • patients expected to be managed in the intensive care unit (ICU) postoperatively and be sedated for more than 24 hours
  • patients undergoing a subsequent amputation who have already been enrolled to participate in the PLACEMENT trial.
  • Patients who met the inclusion criteria but who subsequently are not suitable for randomisation include:
  • patients where a planned major amputation was not performed (due to either anaesthetic or surgical difficulties)
  • patients where a major amputation was performed but the appropriate nerve was not identified
  • patients who, due to instability in the intra-operative period, require admission to the ICU postoperatively and are most likely to be sedated for more than 24 hours
  • patients who, due to instability in the intra-operative period, are not expected to survive more than two weeks

研究者

相似试验